The Gross Margin of Celon Pharma SA (CLN.WA) is 70.12%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 70.12% |
| 2022-12-31 | 65.54% |
| 2021-12-31 | 69.00% |
| 2020-12-31 | 77.10% |
| 2019-12-31 | 77.16% |
| 2018-12-31 | 77.50% |
| 2017-12-31 | 77.16% |
| 2016-12-31 | 77.88% |
| 2015-12-31 | 76.30% |